Drug Res (Stuttg) 2021; 71(07): 363-371
DOI: 10.1055/a-1494-3087
Review

Pain Relief by Analgesic Eardrops: Paradigm Shift in the Treatment of Acute Otitis Media?

Olaf Michel
1   Universitair Ziekenhuis - Vrije Universiteit Brussel UZ-VUB, Belgium
› Author Affiliations

Abstract

Acute otitis media is a common middle ear infection in children with the predominant symptoms of hearing impairment and pain. If antibiotics are given, they need time to have an effect on the inflammation, so the focus is on pain control. For pain management local anesthetics have the advantage of lesser systemic side effects but are still subject to scrutiny. In this review the literature between 2000 and 2020 was systematically searched for investigating studies and recommendation in guidelines against the background of the mode of action. 11 clinical studies, 2 guidelines and 5 reports resp. reviews could be identified. Contraindications and side effects were not found in these studies. The analgesic ear drops showed in placebo-controlled studies a relatively short duration of action when applied once but rapid onset of action. There is evidence that analgesic ear drops could provide a first-line analgesia in otitis media without systemic adverse effects such as gastrointestinal disturbance and nausea and could support an antibiotic-saving wait-and-see attitude. The review shows a change in attitude towards the recommendation to include local anesthetics ear drops in otitis media but still there is a lack in treatment protocols which go beyond a single administration. The results do not yet show a significant paradigm shift. The reviews revealed indications that a more adapted galenic preparation could give more effectiveness. Pharmaceutical research in this field should be intensified to exploit the analgesic potential of local anesthetic ear drops in acute otitis media.



Publication History

Received: 11 February 2020

Accepted: 25 April 2020

Article published online:
07 June 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Coker TR, Chan LS, Newberry SJ. et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: A systematic review. JAMA 2010; 304: 2161-2169. DOI: 10.1001/jama.2010.1651.
  • 2 Kaur R, Morris M, Pichichero ME. Epidemiology of acute otitis media in the postpneumococcal conjugate vaccine era. Pediatrics 2017; 140 DOI: 10.1542/peds.2017-0181.
  • 3 Rovers MM, Glasziou P, Appelman CL. et al. Predictors of pain and/or fever at 3 to 7 days for children with acute otitis media not treated initially with antibiotics: A meta-analysis of individual patient data. Pediatrics 2007; 119: 579-585 /10.1542/peds.2006-2092
  • 4 Suzuki HG, Dewez JE, Nijman RG. et al. Clinical practice guidelines for acute otitis media in children: A systematic review and appraisal of European national guidelines. BMJ open 2020; 10: e035343
  • 5 Siddiq S, Grainger J. The diagnosis and management of acute otitis media: American Academy of Pediatrics Guidelines 2013. Archives of Disease in Childhood-Education and Practice 2015; 100: 193-197
  • 6 Carlens J, Schütz K, Baumann U. Akute Otitis media. Monatsschr Kinderheilkd 2016; 164: 349-358. DOI: 10.1007/s00112-016-0082-2.
  • 7 Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V. Ohrenschmerzen, Stand: 30.09.2020
  • 8 Lieberthal AS, Carroll AE, Chonmaitree T. et al. From the American Academy of Pediatrics: The diagnosis and management of acute otitis media. Pediatrics 2013; 131: e964-e999. DOI: 10.1542/peds.2012-3488.
  • 9 Grevers G. Challenges in reducing the burden of otitis media disease: an ENT perspective on improving management and prospects for prevention. Int J Pediatr Otorhinolaryngol 2010; 74: 572-577. DOI: 10.1016/j.ijporl.2010.03.049.
  • 10 Lautermann J, Begall K, Hilger G. et al. Leitlinie „Seromukotympanum “–Langfassung. HNO 2012; 60: 540-544
  • 11 Venekamp RP, Damoiseaux RA, Schilder AG. Acute otitis media in children. BMJ clinical evidence 2014; 2014: 0301
  • 12 Paulsen F. Muzine auf dem Gebiet der HNO-Heilkunde. HNO 2002; 50: 209-216
  • 13 Buzatto G, Tamashiro E, Proenca-Modena J. et al. The pathogens profile in children with otitis media with effusion and adenoid hypertrophy. PLoS One 2017; 12: e0171049
  • 14 Thomas JP, Berner R, Zahnert T. et al. Strukturiertes Vorgehen bei akuter Otitis media. Dtsch Arztebl Int 2014; 111: 151-160 DOI: 10.3238/arztebl.2014.0151.
  • 15 Linck A. „Otalgan” und andere Illusionen und Irrtümer in der Therapie der Oto-Rhino-Laryngologie. Archiv für Ohren-, Nasen-und Kehlkopfheilkunde 1938; 145: 216-230
  • 16 Breuninger H. Sinn und Unsinn der Anwendung von Ohrtropfen. Laryngologie, Rhinologie, Otologie und ihre Grenzgebiete 1983; 62: 280-283. DOI: 10.1055/s-2007-1008432.
  • 17 Uddman R, Grunditz T, Larsson A. et al. Sensory innervation of the ear drum and middle-ear mucosa: Retrograde tracing and immunocytochemistry. Cell Tissue Res 1988; 252: 141-146
  • 18 Ullrich D, Aurbach G, Drobik C. A prospective study of hyperlipidemia as a pathogenic factor in sudden hearing loss. Eur Arch Otorhinolaryngol 1992; 249: 273-276. DOI: 10.1007/BF00714491.
  • 19 Reiß M. Facharztwissen HNO-Heilkunde: Differenzierte Diagnostik und Therapie. Springer Science & Business Media; 2009
  • 20 Rosen S. The tympanic plexus: an anatomic study. Arch Otolaryngol 1950; 52: 15-18 DOI: 10.1001/archotol.1950.00700030034003.
  • 21 Nagai T, Nagai M, Nagata Y. et al. The effects of anesthesia of the tympanic membrane on eustachian tube function. Archives of Oto-rhino-laryngology 1989; 246: 210-212. DOI: 10.1007/BF00453664.
  • 22 Costen JB, Clare MH, Bishop GH. The transmission of pain impulses via the chorda tympani nerve. Annals of Otology, Rhinology & Laryngology 1951; 60: 591-609
  • 23 Saunders R, Weider D. Tympanic membrane sensation. Brain: A journal of Neurology 1985; 108: 387. DOI: 10.1093/brain/108.2.387.
  • 24 Rockley T, Hawke W. The middle ear as a baroreceptor. Acta Otolaryngol (Stockh) 1992; 112: 816-823. DOI: 10.3109/00016489209137479.
  • 25 Hoskison E, Daniel M, Al-Zahid S. et al. Drug delivery to the ear. Therapeutic delivery 2013; 4: 115-124. DOI: 10.4155/tde.12.130.
  • 26 Schmidt S, Hellström S. Phenol anesthesia of the tympanic membrane in purulent otitis media: a structural analysis in the rat. Eur Arch Otorhinolaryngol 1993; 249: 470-472. DOI: 10.1288/00005537-197802000-00010.
  • 27 Blessing R, Schlenter W. Oberflächenanästhesie des Trommelfells mit DMSO und Lokalanästhetika. Laryngo-Rhino-Otologie 1990; 69: 285-288. DOI: 10.1055/s-2007-998191.
  • 28 Hoberman A, Paradise JL, Reynolds EA. et al. Efficacy of Auralgan for treating ear pain in children with acute otitis media. Archives of Pediatrics & Adolescent Medicine 1997; 151: 675-678
  • 29 Uhde G. The problem of permeability and anesthesia of the tympanic membrane. AMA Archives of Otolaryngology 1957; 66: 391-407. DOI: 10.1001/archotol.1957.03830280021004.
  • 30 Abramson M. Topical anesthesia of the tympanic membrane. Arch Otolaryngol 1969; 90: 147-149
  • 31 Møller Å, Grøntved A. Topical anaesthesia of the normal tympanic membrane: a controlled clinical trial of different suspensions of lidocaine. ORL 1990; 52: 168-173
  • 32 Rahm W, Strother W, Gulick W. et al. LXX The Effects of Anesthetics upon the Ear II. Procaine Hydrochloride. Annals of Otology, Rhinology & Laryngology 1960; 69: 969-975. DOI: 10.1177/000348946006900402.
  • 33 Wada S-I, Starr A. Generation of auditory brain stem responses (ABRs). I. Effects of injection of a local anesthetic (procaine HCl) into the trapezoid body of guinea pigs and cat. Electroencephalogr Clin Neurophysiol 1983; 56: 326-339
  • 34 Kasaba T, Onizuka S, Takasaki M. Procaine and mepivacaine have less toxicity in vitro than other clinically used local anesthetics. Anesthesia & Analgesia 2003; 97: 85-90
  • 35 Khanal S, Modi R, Akhtar K. et al. Benzocaine-Associated Methemoglobinemia. Am J Ther 2018; 25: e771-e772
  • 36 Guay J. Methemoglobinemia related to local anesthetics: a summary of 242 episodes. Anesthesia & Analgesia 2009; 108: 837-845
  • 37 Schmidt RM, Rosenkranz HS. Antimicrobial activity of local anesthetics: lidocaine and procaine. The Journal of Infectious Diseases 1970; 597-607
  • 38 Mühlenfeld H-M, Saal K. Die neue DEGAM-Leitlinie Nr. 7 „Ohrenschmerzen”. ZFA-Zeitschrift für Allgemeinmedizin 2005; 81: 544-549
  • 39 Francois M. Efficacité et tolérance d'une application locale de phénazone et de chlorhydrate de lidocaïne (Otipax) dans les otites congestives du nourrisson et de l'enfant. Ann Pediatr (Paris) 1993; 40: 481-484
  • 40 Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde - Kopf- und Hals-Chirurgie e. V. S2K-Leitlinie Antibiotikatherapie bei HNO-Infektionen. In: Düsseldorf: AWMF 2019
  • 41 Bolt P, Barnett P, Babl FE. et al. Topical lignocaine for pain relief in acute otitis media: results of a double-blind placebo-controlled randomised trial. Arch Dis Child 2008; 93: 40-44
  • 42 Foxlee R, Johansson AC, Wejfalk J. et al. Topical analgesia for acute otitis media (with update 11 feb 2011). Cochrane Database Syst Rev 2006
  • 43 AAP/AAFP. American Academy of Pediatrics, American Academy ol Family Physicians, clinical practical guideline. Subcommittee on Management of Acute Otitis Media. Diagnosis and Management of Acute Otitis Media. Pediatrics 2013; 131: e964–e999
  • 44 Wood DN, Nakas N, Gregory CW. Clinical trials assessing ototopical agents in the treatment of pain associated with acute otitis media in children. Int J Pediatr Otorhinolaryngol 2012; 76: 1229-1235. DOI: 10.1016/j.ijporl.2012.05.022.
  • 45 Laine MK, Tähtinen PA, Ruuskanen O. et al. Symptoms or symptom-based scores cannot predict acute otitis media at otitis-prone age. Pediatrics 2010; 125: e1154-e1161. DOI: 10.1542/peds.2009-2689.
  • 46 Thompson M, Vodicka TA, Blair PS. et al. Duration of symptoms of respiratory tract infections in children: Systematic review. Bmj 2013; 347: f7027
  • 47 Glasziou PP, Del Mar CB, Sanders SL. et al. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 2004; DOI: 10.1002/14651858.CD000219.pub2: Cd000219.
  • 48 Hay AD, Downing H, Francis NA. et al. Anaesthetic–analgesic ear drops to reduce antibiotic consumption in children with acute otitis media: the CEDAR RCT. Health Technology Assessment 2019; 23. DOI: 10.3310/hta23340.
  • 49 Hoberman A, Paradise JL, Rockette HE. et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med 2011; 364: 105-115
  • 50 Spiro DM, Tay K-Y, Arnold DH. et al. Wait-and-see prescription for the treatment of acute otitis media: a randomized controlled trial. JAMA 2006; 296: 1235-1241. DOI: 10.1001/jama.296.10.1235.
  • 51 Venekamp RP, Burton MJ, van Dongen TM. et al. Antibiotics for otitis media with effusion in children. Cochrane Database Syst Rev 2016; DOI: 10.1002/14651858.CD009163.pub3
  • 52 Bertin L, Pons G, dʼAthis P. et al. A randomized, double-blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children. Fundamental & clinical pharmacology 1996; 10: 387-392. DOI: 10.1111/j.1472-8206.1996.tb00590.x.
  • 53 Graham GG, Davies MJ, Day RO. et al. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology 2013; 21: 201-232
  • 54 Hay AD, Costelloe C, Redmond NM. et al. Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): randomised controlled trial. Bmj 2008; 337. DOI: 10.1136/bmj.a1302.
  • 55 Sjoukes A, Venekamp RP, van de Pol AC. et al. Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children. Cochrane Database Syst Rev 2016; DOI: 10.1542/peds.2012-3488.
  • 56 Sarrell EM, Mandelberg A, Cohen HA. Efficacy of naturopathic extracts in the management of ear pain associated with acute otitis media. Archives of pediatrics & adolescent medicine 2001; 155: 796-799. DOI: 10.1001/archpedi.155.7.796.
  • 57 Sarrell EM, Cohen HA, Kahan E. Naturopathic treatment for ear pain in children. Pediatrics 2003; 111: e574-e579
  • 58 Walson P, Wason S, McClain T. et al. Double-blind, placebo-controlled comparison of Auralgan and Americaine for the treatment of otalgia associated with Otitis Media in children. Clinical Pharmacology & Therapeutics 2004; 75: P74-P74 DOI: 10.1016/j.clpt.2003.11.280.
  • 59 Adam D, Federspil P, Lukes M. et al. Therapeutic properties and tolerance of procaine and phenazone containing ear drops in infants and very young children. Arzneimittelforschung 2009; 59: 504-512
  • 60 Schwedt G. Einführung in die Pharmazeutische Chemie. Springer; 2019
  • 61 Wright S. Topical aqueous 2% lignocaine eardrops reduced ear pain in children with acute otitis mediaCommentary. Evid Based Nurs 2008; 11: 107-107. DOI: 10.1136/ebn.11.4.107.
  • 62 Thornton K, Parrish F, Swords C. Topical vs. systemic treatments for acute otitis media. Pediatr Nurs 2011; 37: 263
  • 63 Teschner M. Evidenz und Evidenzlücken zur Behandlung der gestörten Mittelohrbelüftung sowie der Otitis media. Laryngo-Rhino-Otologie 2016; 95: S136-S154. DOI: 10.1055/s-0041-108952.
  • 64 Schilder AG, Marom T, Bhutta MF. et al. Panel 7: otitis media: treatment and complications. Otolaryngology–Head and Neck Surgery 2017; 156: S88-S105
  • 65 Rosa-Olivares J, Porro A, Rodriguez-Varela M. et al. DOI: 10.1542/pir.36-11-480
  • 66 Vergison A, Dagan R, Arguedas A. et al. Otitis media and its consequences: beyond the earache. The Lancet infectious diseases 2010; 10: 195-203
  • 67 Michel O. Zertifizierte Fortbildung: Lokalanästhetika in der HNO-Heilkunde. HNO-Nachrichten 2011; 41: 41-45
  • 68 Michel O. Otitis externa gezielt behandeln. HNO Nachrichten 2017; 47: 38-45
  • 69 Michel O. [External otitis and otitis media: diagnostics and treatment]. MMW Fortschritte der Medizin 2010; 152: 38-42
  • 70 Mösges R, Kaatz V, Schmalz P. et al. Glycerol lidocaine eardrops for the treatment of acute abacterial otitis externa. Arzneimittelforschung 2010; 60: 427-431
  • 71 Ersner MS, Saltzman M. XLIV Ear Drops in Acute Otitis Media: An Evaluation of Various Medicaments and an Analysis of the Untoward Effects of Antipyrine and Benzopyrine. Annals of Otology, Rhinology & Laryngology 1942; 51: 471-475. DOI: 10.1177/000348944205100217.
  • 72 Oleszczuk M, Fernandes RM, Thomson D. et al. The Cochrane Library and acute otitis media in children: an overview of reviews. Evidence-Based Child Health: A Cochrane Review Journal 2012; 7: 393-402. DOI: 10.1002/ebch.1839.
  • 73 Yang R, Saarinen R, Okonkwo OS. et al. Transtympanic delivery of local anesthetics for pain in acute otitis media. Mol Pharm 2019; 16: 1555-1562
  • 74 Matthias R, Handrock M. Zur Wirkung ototoxischer Substanzen bei intratympanaler Applikation. Archives of Oto-rhino-laryngology 1980; 227: 417-420. DOI: 10.1007/BF00467544.
  • 75 Prasad S, Ewigman B. Use anesthetic drops to relieve acute otitis media pain. The Journal of Family Practice 2008; 57: 370
  • 76 Pulkki J, Huikko S, Rautakorpi U-M. et al. Management of pain in acute otitis media in Finnish primary care. Scand J Infect Dis 2006; 38: 265-267 DOI: 10.1080/00365540500434679.
  • 77 Van Uum RT, Venekamp RP, Schilder AG. et al. Pain management in acute otitis media: A qualitative study of parents’ views and expectations. BMC family practice 2019; 20: 18. DOI: 10.1186/s12875-019-0908-9.